
Drug-manufacturing facility seen as catalyst for pharma development
The $80.5 million in federal money going into the Edmonton-based Canadian Critical Drug Initiative will do more than secure a domestic supply of crucial medications and support the commercialization of new drug discoveries, says the head of Applied Pharmaceutical Innovation (API).
By
Karen Unland